Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology. [electronic resource]
- Inflammatory bowel diseases 09 2016
- 2265-79 p. digital
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1536-4844
10.1097/MIB.0000000000000858 doi
Anti-Inflammatory Agents--therapeutic use Chemokines--metabolism Gene Expression Regulation--drug effects Humans I-kappa B Kinase--genetics Inflammatory Bowel Diseases--drug therapy Interleukin-1beta--genetics Interleukin-6--metabolism NF-kappa B p52 Subunit--genetics Signal Transduction Tumor Necrosis Factor-alpha--antagonists & inhibitors